SCHEMBL26046019

SCHEMBL26046019

CC(=O)Cc1ccc(Cl)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.51
PTK2 Q05397 1/20 0.49
L3MBTL1 Q9Y468 3/20 0.43
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.40
MAOB P27338 1/20 0.40
MAPK1 P28482 2/20 0.40
GLA P06280 1/20 0.40
PLAU P00749 1/20 0.39
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
MAPT P10636 1/20 0.39
DAO P14920 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12984996 0.82 L3MBTL1 (0.44) TDP1PTK2L3MBTL1RAB9ANPC1
SCHEMBL2312226 0.81 ADRA2A (0.47) TDP1PTK2L3MBTL1RAB9ANPC1
SCHEMBL28089117 0.80 ALDH1A1 (0.49) TDP1PTK2L3MBTL1RAB9ANPC1
SCHEMBL11099285 0.80 ESR1 (0.49)
SCHEMBL31191353 0.79 L3MBTL1 (0.42) TDP1PTK2L3MBTL1RAB9ANPC1
Hydrochloric Acid SCHEMBL933110 0.79 ADRA2A (0.49) TDP1PTK2L3MBTL1RAB9ANPC1
SCHEMBL7229581 0.78 RAB9A (0.44) TDP1RAB9ANPC1PLAUADRA2A
SCHEMBL13172597 0.78 MAPT (0.50) TDP1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL30728065 0.77 ADRA2A (0.40) L3MBTL1RAB9ANPC1ADRA2AADRA2B
SCHEMBL13754672 0.77 KDM4E (0.46) RAB9ANPC1MAPK1PLAUADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11737463-B2 Pyridine and pyrazine compounds BASF SE (DE) 2023-08-29 US disclosed
US-8841331-B2 Inhibitors of human immunodeficiency virus replication GILEAD SCIENCES, INC. (US) 2014-09-23 US disclosed
US-20110071289-A1 AMINOPYRAZOLE AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2011-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11737463-B2 Pyridine and pyrazine compounds NDUFS5, IL5, NDUFS4 TDP1 1669/4885PTK2 3604/4885L3MBTL1 4849/4885
US-20110071289-A1 AMINOPYRAZOLE AMIDE DERIVATIVE ARGLU1, ARG1, CNKSR1 TDP1 2061/4885PTK2 3477/4885L3MBTL1 3062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.